To conclude, none of the recurrent HOXB13 mutations that we identified in the Dutch population were associated with breast cancer risk, although it may be worthwhile to evaluate p.R217C in a larger study or a population with a higher allele frequency. The gene discussed is HOXB13; the disease is breast cancer.